Welcome to LookChem.com Sign In|Join Free

CAS

  • or

200184-86-7

Post Buying Request

200184-86-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

200184-86-7 Usage

Explanation

Different sources of media describe the Explanation of 200184-86-7 differently. You can refer to the following data:
1. The molecular formula represents the number of atoms of each element present in a molecule of the compound.
2. Derivative of Pyrrolidinedicarboxylic Acid
2. The compound is derived from Pyrrolidinedicarboxylic acid, which is a four-membered cyclic carboxylic acid.
3. Pharmaceutical and Chemical Industries
3. It is commonly used in these industries due to its potential applications in the synthesis of various organic compounds and as a building block for new drugs and molecules.
4. The compound's structure and properties make it suitable for use in the synthesis of a wide range of organic compounds, as well as in the development of new pharmaceuticals.
5. The compound has two chiral centers, with the R configuration at both the 2nd and 4th positions, indicating the specific arrangement of atoms in the molecule.
6. Versatile and Valuable Chemical Compound
6. Due to its specific properties and potential uses, the compound is considered versatile and valuable for various industrial processes and applications.
7. The compound can be used as a starting material or building block in the synthesis of new and complex molecules, particularly in the pharmaceutical industry.
8. The compound's properties make it suitable for use in a wide range of industrial processes, including the synthesis of new drugs, organic compounds, and other chemical products.

Potential Applications

Synthesis of organic compounds and preparation of new drugs and molecules

Chirality

(2R,4R)-

Building Block

Preparation of new molecules

Industrial Processes

Various applications

Check Digit Verification of cas no

The CAS Registry Mumber 200184-86-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,0,1,8 and 4 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 200184-86:
(8*2)+(7*0)+(6*0)+(5*1)+(4*8)+(3*4)+(2*8)+(1*6)=87
87 % 10 = 7
So 200184-86-7 is a valid CAS Registry Number.

200184-86-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-O-tert-butyl 2-O-methyl 4-methoxypyrrolidine-1,2-dicarboxylate

1.2 Other means of identification

Product number -
Other names 4-methoxypyrrolidine-1,2-dicarboxylic acid O1-tert-butyl ester O2-methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:200184-86-7 SDS

200184-86-7Relevant articles and documents

HUMAN PLASMA KALLIKREIN INHIBITORS

-

Page/Page column 211-212, (2017/05/10)

Disclosed are compounds of formula I, and pharmaceutically acceptable salts thereof. The compounds are inhibitors of plasma kallikrein. Also provided are pharmaceutical compositions comprising at least one compound of the invention, and methods involving use of the compounds and compositions of the invention in the treatment and prevention of diseases and conditions characterized by unwanted plasma kallikrein activity.

QUINAZOLINE DERIVATIVES

-

Page/Page column 102, (2008/06/13)

The invention concerns quinazoline derivatives of Formula (I) wherein each of R1, R3, R20, X1, X2, Z, W, (a) and (q) have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of turnours which are sensitive to inhibition of erbB receptor tyrosine kinases, particularly EGFR tyrosine kinase.

Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade

-

, (2008/06/13)

The present invention provides compounds of Formula (I): wherein A, B, C, G, and W1 have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 200184-86-7